MultiFiltrate devices using software version 5.2 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Fresenius Medical Care AG & Co 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-09-17
  • 사례 출판 날짜
    2013-09-17
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: fresenius medical care multifiltrate devices using software version 5.2 the medicines and healthcare products regulatory agency (mhra), united kingdom (uk) posted a medical device safety alert concerning all multifiltrate devices using software version 5.2 manufactured by fresenius medical care ag & co. kgaa. the manufacturer has become aware of a software error when using the substitution bolus function during a continuous renal replacement therapy (crrt) treatment. in one case the substitution bolus unintentionally did not stop after 100 ml. in the worst case, a started substitution bolus is not controlled and automatically stopped by the machine and continues until manually stopped by the user. this situation can lead to severe volume overload and subsequently cause a serious health deterioration or even death. the manufacturer will provide the users with software update as soon as possible. meanwhile, users are strongly recommended to stop using the substitution bolus functionality. in case a fluid bolus is required during crrt, it is recommended that users should use the same process as applied in non-crrt treated patients, e.G. direct infusion of a suitable infusion solution. for details, please visit the following mhra website: http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/fieldsafetynotices/con314890 if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 17 september 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Fresenius Medical Care MultiFiltrate devices using software version 5.2
  • Manufacturer

Manufacturer